TNKase: payments to doctors
Payments that named TNKase as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $777K
- Providers
- 466
- Transactions
- 771
- Average per transaction
- $1,008
The per-transaction average — $1,008 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 466 providers the average total is $1,667, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Genentech, Inc. | $518,590 | 66.7% |
| Genentech USA, Inc. | $237,064 | 30.5% |
| F. Hoffmann-la Roche AG | $21,327 | 2.7% |